Free Newsletter
Enzyme discovery offers new direction in diabetes
A team of Australian scientists has found an enzyme in diabetics that prevents them from producing insulin. The researchers say that they intend to start working with drug developers to block PKCepsilon, raising the possibility of a simple, effective method for treating diabetes. Observers also noted that the advancement could create a therapy that would protect people at high risk from ever developing Type 2 diabetes. In an animal study, the team developed genetically modified mice without the enzyme, and found that they didn't develop diabetes even after gaining a significant amount of weight on a high-fat diet.
- see the release on the discovery
- read the the report from ABC
Related Articles:
New way to creating enzymes. Report
Diabetes epidemic triggers soaring drug market. Report
Diabetes therapies move into the research spotlight. Report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceBiotech Research email newsletter for FREE!
Be the first to comment